Anna-Maria Alves, MS, Associate Scientist

Anna is responsible for developing new assays to increase understanding of the role of progranulin in neurodegenerative diseases and assessing new therapies. Anna is passionate about developing therapies for patients with unmet medical needs while improving quality of life for individuals with neurodegenerative conditions. Prior to Arkuda, Anna worked in drug discovery for six years at Sanofi-Genzyme and Navitor Pharmaceuticals. She completed her MS in cellular and molecular biology at UMass Amherst.